A third dose of Pfizer and BioNTech’s COVID-19 vaccine produced significant protection against the Omicron variant of the coronavirus in healthy children ages 5 to 11, the companies said. Analysis of 30 participants who received a booster dose showed a 36-fold increase in neutralizing antibodies to Omicron.